Skip to main content

Ginny Lynn Schulz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Ginny Schulz's full profile

Already have an account?

Summary

  • Areas of interest: pediatric stem cell transplant in nonmalignant disease; family and pediatric treatment decision-making; and impact of psychosocial factors on stem cell transplant outcomes

Certifications & Licensure

  • Pediatric Nursing Certification Board Pediatric Nurse Practitioner Primary Care
  • Association of Pediatric Hematology/Oncology NursesChemotherapy/Biotherapy Provider

Education & Training

  • University of Missouri
    University of MissouriPhD candidate, Nursing, 2013
  • University of North Carolina
    University of North CarolinaCertificate, Family Research Institute: Conceptual and Methodological Issues, 2016
  • University of Missouri
    University of MissouriMasters, 2011
  • University of Missouri
    University of MissouriBSN, Nursing, 2006
  • University of Missouri
    University of MissouriPost-Masters Certificate

Awards, Honors, & Recognition

  • Awarded PhD Student Award in Overall Excellence University of Missouri-Columbia, 2017
  • Nominee for Graduate Leadership Development Program University of Missouri-Columbia, 2016
  • Awarded V. James & Verna Adwell Rhodes Endowed Nursing Fellowship University of Missouri-Columbia, 2014
  • Join now to see all

Professional Memberships

Publications & Presentations

PubMed

Journal Articles

  • Sickle cell disease and hematopoietic stem cell transplantation: Exploring alternative donors  
    Schulz, G, APHON Counts, 2015
  • Evidence-based practice recommendations for hydration in children and adolescents with cancer receiving intravenous Cyclophosphamide  
    Robinson, D., Schulz, G., Langley, R., Donze, K., Winchester, K., & Rodgers, C., Journal of Pediatric Oncology Nursing, 2014

Abstracts/Posters

  • A single center experience using alemtuzumab, fludarabine, melphlan, and thiotepa as conditioning for transplant in chronic granulomatous disease
    Bhatt, S., Schulz, G., Shenoy, S., & Bednarski, J. J., BMT Tandem Meeting, American Society for Blood and Marrow Transplantation, 2/2017
  • Describing psychosocial barrier to minimize stem cell transplant complications in pediatric patients with sickle cell disease: A case study approach.
    Schulz, G., Foster, R., Kennedy, V., Towerman, Alison., Holtmann, M. (, BMT Tandem Meeting, American Society for Blood and Marrow Transplantation, 2/2017
  • The comparison of 100 day chimerism in pediatric nonmalignant allogeneic stem cell transplant patients receiving subcutaneous versus intravenous Alemtuzumab: One Insti...
    Langley, R. C., Schulz, G., Bednarski, J. J., & Hente, M. L., APHON Conference Association of Pediatric Hematology/Oncology Nurses, 9/2016
  • Join now to see all

Grant Support

  • Decision Making in Pursuing Hematopoietic Stem Cell TransplantationAmerican Cancer Society2017–2019
  • Understanding Decisional Conflict in Families of Children and Adolescents with Sickle Cell Disease: Should We Choose Hematopoietic Cell Transplant?MU Patient-Centered Outcomes Research Institute2017–2018
  • Decision Making in Pursuing Hematopoietic Stem Cell TransplantationAmerican Cancer Society2015–2017
  • Office

    1 Childrens Pl
    # Div
    Saint Louis, MO 63110
    Phone+1 314-454-6018
    Fax+1 844-621-4392